Sorting nexins (SNX) represent a diverse family of proteins involved in crucial cellular processes, particularly the regulation of intracellular membrane trafficking and sorting. SNX proteins play a pivotal role in orchestrating the endocytic and recycling pathways within cells, ensuring the precise localization and transport of various membrane-bound cargo proteins. Structurally, SNX proteins are characterized by the presence of one or more phosphoinositide-binding domains, most notably the Phox homology (PX) domain, which enables their association with specific phospholipids in cellular membranes. SNX proteins act as molecular adaptors that interact with other cellular components, such as clathrin, to facilitate the formation of membrane vesicles and the selective sorting of cargo molecules. By recognizing distinct sorting signals in cargo proteins, SNX proteins contribute to the proper routing of cargo between different membrane compartments, including endosomes, lysosomes, the trans-Golgi network, and the plasma membrane. Moreover, SNX proteins can engage in intricate protein-protein interactions with other cellular factors, including GTPases, to modulate membrane dynamics and cellular responses.
Sorting Nexin (SNX) Inhibitors are designed to interfere with the activity or interactions of SNX proteins within the cellular trafficking machinery. These inhibitors serve as valuable tools in research to dissect the roles of SNX proteins and their contributions to membrane dynamics and cargo sorting processes. Some SNX inhibitors may target the phosphoinositide-binding domains of SNX proteins, disrupting their membrane localization and impeding their ability to bind to specific lipids. Others may interfere with protein-protein interactions involving SNX proteins, their association with cargo molecules, adaptors, or other regulatory factors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $255.00 | ||
This compound also inhibits dynamin and can therefore disrupt endocytosis, potentially impacting the cycling of PSGL1 into endosomes. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $428.00 $2652.00 | 5 | |
Apilimod is an inhibitor of phosphoinositide 3-kinase (PI3K) and has been reported to indirectly affect SNX1 and SNX2, which are involved in endosomal trafficking and membrane remodeling. | ||||||
Rasagiline | 136236-51-6 | sc-204875 sc-204875A | 25 mg 100 mg | $101.00 $210.00 | ||
Rasagiline is a monoamine oxidase-B (MAO-B) inhibitor and has been shown to affect SNX7, a member of the SNX family, potentially altering endosomal sorting processes. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA inhibits PI3K, known to affect autophagy. Given the relationship between endosomes and autophagosomes, SNX33 expression might be influenced. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide inhibits SNX8 by interfering with its role in Wnt signaling, leading to the disruption of endosomal cargo sorting. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 inhibits sphingomyelinase, altering lipid composition in endosomes and interfering with SNX8-mediated sorting processes. | ||||||
KPT185 | 1333151-73-7 | sc-487916 | 10 mg | $220.00 | ||
SAR405 inhibits PI3-kinase, disrupting phosphoinositide signaling pathways involved in SNX8-mediated endosomal cargo sorting. | ||||||
URMC-099 | 1229582-33-5 | sc-492603 | 5 mg | $146.00 | ||
PF-543 inhibits SphK1, disrupting sphingolipid metabolism and indirectly affecting SNX8-mediated endosomal sorting processes. | ||||||